Related Experiment Video
Updated: Aug 29, 2025
09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.8K
System Design for Optimizing Drug Infusions Using Cardiovascular Space Mapping for Acute Heart Failure.
Summary
This study introduces an optimized drug infusion system for acute heart failure, effectively managing cardiovascular metrics using tailored drug combinations and dosages. The system also predicts therapy limitations, aiding clinical decisions for critical heart failure patients.
Area of Science:
- Cardiology
- Pharmacology
- Biomedical Engineering
Background:
- Acute heart failure necessitates complex, multi-drug therapies.
- Optimizing cardiovascular drug combinations presents a significant challenge due to intricate pharmacologic interactions.
Purpose of the Study:
- To propose an automated drug infusion system for acute heart failure management.
- To address the multidrug optimization problem by controlling cardiovascular performance metrics.
Main Methods:
- Developed a system modeling and controlling cardiovascular parameters (systemic vascular resistance, cardiac contractility, heart rate, stressed blood volume).
- Employed 'tailored drug infusion' and 'cardiovascular space mapping' techniques for optimization.
- Validated the system using 5,600 simulated patients with realistic parameters.
Main Results:
- Optimized drug combinations and dosages effectively controlled key cardiovascular metrics (cardiac output, left atrial pressure, mean arterial pressure).
- Achieved results largely aligned with clinical guidelines for drug use.
- Successfully predicted limitations of tailored drug therapy.
Conclusions:
- The proposed system offers a viable approach for optimizing drug therapy in acute heart failure.
- The system aids clinical decision-making by identifying when alternative treatments like mechanical support may be needed.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
01:30Heart Failure V: Medical Management
21
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
21
01:22Heart Failure Drugs: Diuretics
462
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
462
01:30Heart Failure VII: Nursing Interventions
131
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
131
01:15Two-Compartment Open Model: IV Infusion
319
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
319
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
489
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
489